Correction to: A Subepithelial Lesion in the Colon Masquerading as Metastatic Prostate Cancer [0.03%]
Correction to：一项误诊为转移性前列腺癌的结肠亚黏膜病变病例报告
Rahil H Shah,Michael D Brophey,Megan Wachsmann et al.
Rahil H Shah et al.
[This corrects the article DOI: 10.14309/crj.0000000000001689.]. © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The America...
Published Erratum
ACG case reports journal. 2025 Jun 13;12(6):e01735. DOI:10.14309/crj.0000000000001735 2025
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial [0.03%]
初始转移性前列腺癌联合细胞减灭术、放疗或消融的IP2-ATLANTA内部预试验二期随机对照试验
Martin J Connor,Taimur T Shah,Johanna Sukumar et al.
Martin J Connor et al.
Background and objective: Cytoreduction of the primary prostate cancer, involved lymph nodes, and metastases may confer improved cancer control in de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC). ...
Debate 3: Metastasis Directed Therapy in Oligometastatic Prostate Cancer [0.03%]
寡转移前列腺癌的转移灶导向治疗辩论会三期
Maneesh Singh,Vedang Murthy,Piet Ost
Maneesh Singh
Oligometastatic prostate cancer (OMPC), characterized by limited metastatic burden (≤5 lesions), encompasses 3 major subtypes: de novo synchronous oligometastatic hormone-sensitive prostate cancer (om-HSPC), metachronous oligorecurrent HSP...
Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer [0.03%]
下调NONO可抑制转移性前列腺癌的增殖、迁移和侵袭
Anna-Lena Lemster,Sarah Grünhagen,Sarah Schmalfeld et al.
Anna-Lena Lemster et al.
Background: As prostate cancer (PCa) remains one of the leading causes of cancer-related death in men, it is important to develop effective therapeutic approaches for the treatment of metastatic PCa and to improve the acc...
The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand Therapy [0.03%]
放射配体治疗对SARS-CoV-2免疫原性影响的单臂队列研究：接受前列腺癌PSMA放射配体治疗的转移性前列腺癌患者的回顾性研究
Carsten S Kramer,Aleksandr Eismant,Aditi Mishra et al.
Carsten S Kramer et al.
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a rising threat for immunocompromised cancer patients. The reduced immune defense may be a result of the malignancy itself or a side effect of therapy. Whil...
Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors [0.03%]
雄激素受体信号传导抑制剂治疗的转移性前列腺癌患者中糖尿病与急性护理使用情况的关系
Michael A Liu,Rohit Raghunathan,Karie Runcie et al.
Michael A Liu et al.
Purpose: Androgen receptor signaling inhibitors (ARSIs) are mainstay treatments for metastatic prostate cancer. Hyperglycemia is a common side effect, but limited data exist on outcomes such as acute care use among patien...
Transperineal US-Guided Biopsy in Metastatic Prostate Cancer with Low Prostate Specific Antigen: A Case Report [0.03%]
低前列腺特异性抗原转移性前列腺癌的经会阴超声引导活检：一例报告
Seongeun Jung,Seong Sook Hong,Sung Hwan Bae et al.
Seongeun Jung et al.
Prostate specific antigen (PSA) is a crucial tool for detecting and monitoring of prostate cancer, and elevated levels of PSA often indicate disease progression. Higher PSA levels are generally associated with more aggressive cancers and an...
Phosphorescence-based [Formula: see text] sensing reveals size-dependent survival and motility of metastatic prostate cancer cells in self-generated hypoxia [0.03%]
一种基于光致发光的[公式见原文]传感器，可揭示前列腺癌转移细胞在自我生成缺氧环境下的大小依赖性生存和运动能力
Noreen Hosny,Kimberly Shen,Yihua Zhao et al.
Noreen Hosny et al.
Cancer cells in solid tumors experience hypoxia, a condition of low O 2 concentration, since their O 2 demand exceeds the supply from the surrounding vasculature. However, how these cells adapt to hypoxia requires further elucidation....
Metastatic prostate cancer in the inferior mesenteric artery territory lymph nodes following anterior resection for colon cancer [0.03%]
经前切除术后继发于肠癌的腹主动脉区域淋巴结前列腺癌转移病患者的治疗
Lydia Li Yeh Tan,Gwyneth Shook-Ting Soon,Dedrick Kok Hong Chan
Lydia Li Yeh Tan
Prostate cancer metastasises via haematogenous or lymphatic routes and may be found at atypical sites. This is the first reported case of metastatic prostate cancer in the lymph nodes of the inferior mesenteric artery distribution following...
Case Reports
BMJ case reports. 2025 Jun 4;18(6):e266095. DOI:10.1136/bcr-2025-266095 2025
Combination prostate-specific membrane antigen-targeted radiopharmaceutical therapy in metastatic prostate cancer [0.03%]
用于转移性前列腺癌的前列腺特异性膜抗原靶向放射性药物治疗联合疗法
Hossein Jadvar,Kambiz Rahbar,Hojjat Ahmadzadehfar et al.
Hossein Jadvar et al.
Radiopharmaceutical therapy is emerging rapidly as an effective and safe pillar in cancer management. The regulatory approvals for 177Lu-PSMA-617 radiopharmaceutical therapy in both the pre- and post-chemotherapy metastatic castration resis...
耗时 0.34776 秒，为您在
48229835
条记录里面共找到 3451 篇文章 [XML]